Piper Sandler Maintains Overweight on Inspire Medical Systems, Raises Price Target to $340
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Adam Mizrahi maintains an Overweight rating on Inspire Medical Systems (NYSE:INSP) and raises the price target from $315 to $340.
June 08, 2023 | 2:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler analyst maintains Overweight rating on Inspire Medical Systems (INSP) and raises price target from $315 to $340.
The news directly mentions Inspire Medical Systems (INSP) and the raised price target by Piper Sandler analyst Adam Mizrahi. This positive outlook from a reputable analyst is likely to have a positive short-term impact on INSP's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100